William H. Carson - Net Worth and Insider Trading
William H. Carson Net Worth
The estimated net worth of William H. Carson is at least $162,400 dollars as of 2024-11-05. William H. Carson is the Director of Annexon Inc and owns about 22,400 shares of Annexon Inc (ANNX) stock worth over $162,400. Details can be seen in William H. Carson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William H. Carson has not made any transactions after 2024-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William H. Carson
William H. Carson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William H. Carson owns 3 companies in total, including Prevail Therapeutics Inc (PRVL) , Annexon Inc (ANNX) , and Decibel Therapeutics Inc (DBTX) .
Click here to see the complete history of William H. Carson’s form 4 insider trades.
Insider Ownership Summary of William H. Carson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PRVL | Prevail Therapeutics Inc | 2020-09-09 | director |
| ANNX | Annexon Inc | 2024-10-01 | director |
| DBTX | Decibel Therapeutics Inc | 2021-06-02 | director |
William H. Carson Latest Holdings Summary
William H. Carson currently owns a total of 1 stock. William H. Carson owns 22,400 shares of Annexon Inc (ANNX) as of October 1, 2024, with a value of $162,400.
Latest Holdings of William H. Carson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ANNX | Annexon Inc | 2024-10-01 | 22,400 | 7.25 | 162,400 |
Holding Weightings of William H. Carson
William H. Carson Form 4 Trading Tracker
According to the SEC Form 4 filings, William H. Carson has made a total of 7 transactions in Annexon Inc (ANNX) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Annexon Inc is the acquisition of 3,200 shares on October 1, 2024, which cost William H. Carson around $19,104.
Insider Trading History of William H. Carson
- 1
William H. Carson Trading Performance
GuruFocus tracks the stock performance after each of William H. Carson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William H. Carson is 13.18%. GuruFocus also compares William H. Carson's trading performance to market benchmark return within the same time period. The performance of stocks bought by William H. Carson within 3 months outperforms 4 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William H. Carson's insider trading performs compared to the benchmark.
Performance of William H. Carson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.01 |  | | | | |
| Relative Return to S&P 500(%) | 2.68 | | | | | |
William H. Carson Ownership Network
Ownership Network List of William H. Carson
Ownership Network Relation of William H. Carson
William H. Carson Owned Company Details
What does Prevail Therapeutics Inc do?
Who are the key executives at Prevail Therapeutics Inc?
William H. Carson is the director of Prevail Therapeutics Inc. Other key executives at Prevail Therapeutics Inc include director & 10 percent owner Carl L Gordon , director & 10 percent owner Peter A. Thompson , and General Counsel Kira M. Schwartz .
Prevail Therapeutics Inc (PRVL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prevail Therapeutics Inc Insider Transactions
William H. Carson Mailing Address
Above is the net worth, insider trading, and ownership report for William H. Carson. You might contact William H. Carson via mailing address: C/o Prevail Therapeutics Inc., 430 East 29th Street, Suite 1520, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
